Volume 1 Number 2 August 2005

Introduction and thoughts on the second issue of EuroIntervention

• Serruys PW

EuroInterv.2005;2:121

Coin of the realm: do only randomized trials count or is ART okay?

• Holmes D

EuroInterv.2005;2:122

The Endeavor Stent System: will it be the next kid in the block? Numero uno, first among equals or equal?

• Waksman R

EuroInterv.2005;2:123-124

Blowing against the wind?

• Wijns W

EuroInterv.2005;2:125-127

Beyond crossing a chronic total occlusion. Are the drug-eluting stents the solution for this old problem?

• García-García HM,
• Valgimigli M,
• Lotan C

EuroInterv.2005;2:129-131

Launching a new journal dedicated to interventional cardiology is a great challenge.

• Lafont A

EuroInterv.2005;2:133

Training in interventional cardiology in Europe: how to move from chaos to rational common programs?

• Di Mario C,
• Lafont A

EuroInterv.2005;2:135-137

EuroPCR highlights 2005

• Malagutti P,
• Valgimigli M,
• de Feyter P

EuroInterv.2005;2:139-144

EuroIntervention: a politician's view

• Douste-Blazy P

EuroInterv.2005;2:145-146

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novocoronary artery lesions

• Serruys PW,
• Ong ATL,
• Morice M-C,
• de Bruyne B,
• Colombo A,
• Macaya C,
• Richardt G,
• Fajadet J,
• Hamm C,
• Dawkins K,
• James A,
• Bressers M,
• Donohoe D

EuroInterv.2005;2:147-156

First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial

• Meredith I,
• Ormiston J,
• Whitbourn R,
• Kay IP,
• Muller D,
• Bonan R,
• Popma J,
• Cutlip D,
• Fitzgerald P,
• Prpic R,
• Kuntz R

EuroInterv.2005;2:157-164

One-year clinical outcome of various doses and pharmacokinetic release of paclitaxel eluted from an erodable polymer - Insights from the Paclitaxel In-Stent Controlled Elution Study (PISCES)

• Aoki J,
• Ong ATL,
• Abizaid A,
• den Heijer P,
• Bonnier H,
• McClean DR,
• Verheye S,
• Belardi J,
• Condado J,
• Pieper M,
• Eduardo Sousa J,
• Bressers M,
• Symons J,
• Litvack F,
• Sianos G,
• Serruys PW

EuroInterv.2005;2:165-172

Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study

• Ribichini F,
• Tomai F,
• Ferrero V,
• Versaci F,
• Boccuzzi G,
• Proietti I,
• Prati F,
• Crea F,
• Vassanelli C

EuroInterv.2005;2:173-180

Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery

• Michels M,
• Caliskan K,
• Ong ATL,
• McFadden E,
• Kappetein AP,
• van Domburg R,
• Serruys PW

EuroInterv.2005;2:181-185

Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry)

• Buszman P,
• Szkróbka I,
• Tendera Z,
• Gruszka A,
• Bialkowska B,
• Parma R,
• Wojakowski W,
• Król M,
• Kiesz SR,
• Bochenek A,
• Tendera M

EuroInterv.2005;2:186-192

Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent

• Hoye A,
• Ong ATL,
• Aoki J,
• van Mieghem CAG,
• Rodríguez-Granillo G,
• Valgimigli M,
• Sianos G,
• McFadden E,
• van der Giessen WJ,
• de Feyter P,
• van Domburg R,
• Serruys PW

EuroInterv.2005;2:193-197

Primary stenting for left-main shock syndrome

• Yamane M,
• Inoue S,
• Yamane A,
• Kinebuchi O,
• Yokozuka H

EuroInterv.2005;2:198-203

150 microgram intracoronary adenosine bolus for accurate fractional flow reserve assessment of angiographically intermediate coronary stenosis

• Rioufol G,
• Caignault J-R,
• Finet G,
• Staat P,
• Bonnefoy E,
• de Gévigney G,
• Rossi R,
• Andre-Fouet X

EuroInterv.2005;2:204-207

Preprocedural creatinine clearance and long term survivalafter successful coronary stenting

• Souibri K,
• Morello R,
• Fradin S,
• Grollier G,
• Ryckelynck J-P,
• Hamon M

EuroInterv.2005;2:208-213

CMR assessment of AMI patients treated by PCI shows delays in myocardial reperfusion despite initial achievement of TIMI 3 flow

• Noël B,
• Morice M-C,
• Garot J,
• Louvard Y,
• Tavolaro O,
• Dumas P,
• Lévy M,
• Garot P,
• Lefèvre T

EuroInterv.2005;2:214-218

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease

• Sianos G,
• Morel M-A,
• Kappetein AP,
• Morice M-C,
• Colombo A,
• Dawkins K,
• van den Brand M,
• van Dyck N,
• Russell ME,
• Serruys PW

EuroInterv.2005;2:219-227

The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model

• Aragon J,
• Kar S,
• Tio F,
• Trauthen B,
• Parisky A,
• Watanabe C,
• Jamali A,
• Eigler N,
• Serruys PW,
• Litvack F

EuroInterv.2005;2:228-235

Inhibition of intimal hyperplasia by the tetracycline derived MMP inhibitor doxycycline in vein graft disease in vitro and in vivo

• Lardenoye JHP,
• de Vries MR,
• Deckers M,
• van Lent N,
• Hanemaaijer R,
• van Bockel JH,
• Quax PHA

EuroInterv.2005;2:236-243

Assessment of stent dimensions with a novel intracoronary balloon-based system: comparative study versus intravascular ultrasound and quantitative coronary angiography. The CAMUS - Coronary Angioplasty Metricath vs. UltraSound Trial

• van der Giessen WJ,
• Regar E,
• McFadden E,
• McDougall I,
• Serruys PW

EuroInterv.2005;2:244-251